Evidence map›Paper›PMID 33481168›Full record

ArticleJournal of general internal medicine2021

Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose.

Jingchuan Guo, Wei-Hsuan Lo-Ciganic, Qingnan Yang, James L Huang, Jeremy C Weiss, Gerald Cochran, Daniel C Malone, Courtney C Kuza, Adam J Gordon, Julie M Donohue and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jingchuan GuoCenter for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA, USA.
Wei-Hsuan Lo-CiganicDepartment of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Qingnan YangCenter for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA, USA.
James L HuangDepartment of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Jeremy C WeissCarnegie Mellon University, Heinz College, Pittsburgh, PA, USA.
Gerald CochranProgram for Addiction Research, Clinical Care, Knowledge, and Advocacy, Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Daniel C MaloneDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
Courtney C KuzaCenter for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA, USA.
Adam J GordonProgram for Addiction Research, Clinical Care, Knowledge, and Advocacy, Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Julie M DonohueDepartment of Health Policy and Management, University of Pittsburgh, Pittsburgh, PA, USA.
Walid F GelladCenter for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA, USA. walid.gellad@pitt.edu.
University of Pittsburgh · USUniversity of Utah · USUniversity of Florida · USCarnegie Mellon University · US

Funding

Using Machine Learning to Predict Problematic Prescription Opioid Use and Opioid OverdoseR01DA044985 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Walid F. Gellad · 2017 to 2026
$5.4M
NIDA NIH HHS R01 DA044985NIDA NIH HHS R01DA044985
6 · The paper itself

Abstract

backgroundSurvivors of opioid overdose have substantially increased mortality risk, although this risk is not evenly distributed across individuals. No study has focused on predicting an individual's risk of death after a nonfatal opioid overdose.

objectiveTo predict risk of death after a nonfatal opioid overdose. DESIGN AND

participantsThis retrospective cohort study included 9686 Pennsylvania Medicaid beneficiaries with an emergency department or inpatient claim for nonfatal opioid overdose in 2014-2016. The index date was the first overdose claim during this period. EXPOSURES, MAIN OUTCOME, AND MEASURES: Predictor candidates were measured in the 180 days before the index overdose. Primary outcome was 180-day all-cause mortality. Using a gradient boosting machine model, we classified beneficiaries into six subgroups according to their risk of mortality (< 25th percentile of the risk score, 25th to < 50th, 50th to < 75th, 75th to < 90th, 90th to < 98th, ≥ 98th). We then measured receipt of medication for opioid use disorder (OUD), risk mitigation interventions (e.g., prescriptions for naloxone), and prescription opioids filled in the 180 days after the index overdose, by risk subgroup. KEY

resultsOf eligible beneficiaries, 347 (3.6%) died within 180 days after the index overdose. The C-statistic of the mortality prediction model was 0.71. In the highest risk subgroup, the observed 180-day mortality rate was 20.3%, while in the lowest risk subgroup, it was 1.5%. Medication for OUD and risk mitigation interventions after overdose were more commonly seen in lower risk groups, while opioid prescriptions were more likely to be used in higher risk groups (both p trends < .001).

conclusionsA risk prediction model performed well for classifying mortality risk after a nonfatal opioid overdose. This prediction score can identify high-risk subgroups to target interventions to improve outcomes among overdose survivors.

Indexed as

Drug OverdoseOpiate OverdoseOpioid-Related DisordersAnalgesics, OpioidEmergency Service, HospitalHospitalsHumansPennsylvaniaRetrospective StudiesUnited StatesAnalgesics, Opioidmachine learningMedicaidmortalitynonfatal opioid overdoseprediction

Identifiers

PMID33481168
PMCPMC8041978
OpenAlexW3122508981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.